Bronchogen
Also known as: Bronchogen
Bronchogen is a short synthetic peptide (Ala-Glu-Asp-Leu) studied as a bronchial bioregulator intended to support respiratory tissue function. It is part of the Russian-developed family of short "Khavinson" peptide bioregulators.
Last updated
Mechanism of Action
Bronchogen is a tetrapeptide (AEDL) classified as a peptide bioregulator believed to act epigenetically by binding regions of DNA and modulating gene expression in bronchial and pulmonary epithelial cells. It is proposed to normalize expression of genes governing differentiation and function of respiratory tract cells, supporting mucosal repair and reducing local inflammatory signaling. Its tissue-selective activity reflects the bioregulator concept that short peptides restore homeostatic protein synthesis in specific organ systems.
- Half-life
- Short (minutes), typical of small tetrapeptides cleared rapidly from circulation
- Administration Routes
- subcutaneous, intramuscular
- Research Status
- Research Chemical
Reported Benefits
- Studied for support of bronchial and lung epithelial function
- May help modulate local respiratory inflammation
- Proposed to promote normal differentiation of respiratory mucosa
- Investigated as adjunct support in chronic bronchopulmonary conditions
- Short peptide structure with generally low antigenicity
Potential Side Effects
- Limited human safety data
- Possible injection-site irritation
- Potential hypersensitivity reactions
- Unverified long-term effects
Common Dosing
For research use only and not medical advice: literature and bioregulator protocols reference courses of roughly 100-200 mcg per day subcutaneously or intramuscularly over 10-20 day cycles; human clinical dosing is not established.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Pregnancy and breastfeeding
- Known peptide hypersensitivity
- Acute febrile or infectious illness without medical oversight
Thymulin
Thymulin is a zinc-dependent thymic nonapeptide hormone that supports T-cell maturation and modulates immune and neuroendocrine signaling. It is studied as an immunoregulatory and anti-inflammatory agent.
Thymagen (Thymogen)
Thymagen (Thymogen) is a short synthetic peptide bioregulator related to thymic function, studied for immune modulation. It is researched for supporting and balancing immune responses.
Chonluten
Chonluten is a short synthetic peptide (Glu-Asp-Gly) studied as a bronchial and lung bioregulator. It belongs to the Khavinson family of short peptide bioregulators and is sometimes designated T-34.
- View
Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology
2015
- View
[ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]
2017
- View
Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability
2011